Md Ali Mujtaba

1.1k total citations
65 papers, 806 citations indexed

About

Md Ali Mujtaba is a scholar working on Pharmaceutical Science, Molecular Biology and Pharmacology. According to data from OpenAlex, Md Ali Mujtaba has authored 65 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pharmaceutical Science, 15 papers in Molecular Biology and 10 papers in Pharmacology. Recurrent topics in Md Ali Mujtaba's work include Advanced Drug Delivery Systems (23 papers), Drug Solubulity and Delivery Systems (15 papers) and Advancements in Transdermal Drug Delivery (11 papers). Md Ali Mujtaba is often cited by papers focused on Advanced Drug Delivery Systems (23 papers), Drug Solubulity and Delivery Systems (15 papers) and Advancements in Transdermal Drug Delivery (11 papers). Md Ali Mujtaba collaborates with scholars based in Saudi Arabia, India and Malaysia. Md Ali Mujtaba's co-authors include Kanchan Kohli, Md Habban Akhter, Mushir Ali, Saima Amin, Kriti Soni, Md. Rizwanullah, Javed Ahmad, Ameeduzzafar Zafar, Javed Ali and Mohamed Jawed Ahsan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain Research and RSC Advances.

In The Last Decade

Md Ali Mujtaba

56 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Md Ali Mujtaba Saudi Arabia 16 311 207 169 121 97 65 806
Phuong Tran South Korea 15 382 1.2× 237 1.1× 154 0.9× 134 1.1× 54 0.6× 35 912
Farhat Fatima Saudi Arabia 18 321 1.0× 140 0.7× 180 1.1× 91 0.8× 50 0.5× 43 773
Khaled Shalaby Saudi Arabia 19 463 1.5× 233 1.1× 205 1.2× 97 0.8× 50 0.5× 40 1.0k
Kwan Hyung Cho South Korea 18 377 1.2× 169 0.8× 150 0.9× 90 0.7× 73 0.8× 64 828
Mohammed Muqtader Ahmed Saudi Arabia 22 436 1.4× 247 1.2× 238 1.4× 136 1.1× 51 0.5× 81 1.1k
Han Gon Choi South Korea 23 285 0.9× 300 1.4× 187 1.1× 100 0.8× 128 1.3× 38 1.0k
Iman Saad Ahmed United Arab Emirates 19 436 1.4× 118 0.6× 142 0.8× 103 0.9× 58 0.6× 42 822
Manju Nagpal India 18 306 1.0× 162 0.8× 152 0.9× 103 0.9× 40 0.4× 76 948
Mohamed A. Shaker Egypt 16 225 0.7× 221 1.1× 196 1.2× 144 1.2× 42 0.4× 26 861
Jin Han China 21 381 1.2× 207 1.0× 176 1.0× 93 0.8× 69 0.7× 52 920

Countries citing papers authored by Md Ali Mujtaba

Since Specialization
Citations

This map shows the geographic impact of Md Ali Mujtaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Md Ali Mujtaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Md Ali Mujtaba more than expected).

Fields of papers citing papers by Md Ali Mujtaba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Md Ali Mujtaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Md Ali Mujtaba. The network helps show where Md Ali Mujtaba may publish in the future.

Co-authorship network of co-authors of Md Ali Mujtaba

This figure shows the co-authorship network connecting the top 25 collaborators of Md Ali Mujtaba. A scholar is included among the top collaborators of Md Ali Mujtaba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Md Ali Mujtaba. Md Ali Mujtaba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kumar, Dinesh, et al.. (2025). Comprehensive insights into the role of nanocarriers in advancing azole-based ocular therapeutics. RSC Advances. 15(45). 37776–37815.
3.
Kaleem, Mohammed, et al.. (2025). Epigenetic dynamics and molecular mechanisms in oncogenesis, tumor progression, and therapy resistance. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(10). 13625–13646. 2 indexed citations
4.
Zafar, Ameeduzzafar, Mohammad Khalid, Omar Awad Alsaidan, & Md Ali Mujtaba. (2025). Exploring the molecular pathways of advanced rectal cancer: A focus on genetic, RNA, and biological technique. Pathology - Research and Practice. 270. 155956–155956. 1 indexed citations
5.
Shan, Hu, Yang Lü, Md Ali Mujtaba, et al.. (2025). Oroxylin A exerts antiproliferative effects through downregulation of E6 and E7 oncogenes in cervical cancer HeLa cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 399(3). 3519–3532.
6.
Satapathy, Bhabani Sankar, Ameeduzzafar Zafar, Musarrat Husain Warsi, et al.. (2025). Luliconazole–niacinamide lipid nanocarrier laden gel for enhanced treatment of vaginal candidiasis: in vitro, ex vivo, in silico and preclinical insights. RSC Advances. 15(8). 5665–5680. 3 indexed citations
7.
Mujtaba, Md Ali, Md Abdur Rashid, Yahya Alhamhoom, et al.. (2025). Design of Experiments Assisted Formulation Optimization and Evaluation of Efavirenz Solid Dispersion Adsorbate for Improvement in Dissolution and Flow Properties. Drug Design Development and Therapy. Volume 19. 3715–3734.
9.
Kaleem, Mohammed, Md Ali Mujtaba, Nilesh Mahajan, et al.. (2024). A Comprehensive Review of Various Therapeutic Strategies for the Management of Skin Cancer. ACS Omega. 9(9). 10030–10048. 9 indexed citations
10.
Iqbal, Amir, et al.. (2024). Efficacy of Scapular Functional and Cervical Isometric Exercises in the Management of Chronic Mechanical Neck Pain: A Randomized Comparative Trial. Pain Research and Management. 2024(1). 5873384–5873384. 1 indexed citations
11.
Mujtaba, Md Ali, Ritesh Fule, S.V. Pande, et al.. (2024). Development of chitosan/sodium carboxymethyl cellulose-based polyelectrolyte complex of dexamethasone for treatment of anterior uveitis. Biomedical Materials. 19(6). 65016–65016. 7 indexed citations
12.
13.
Mujtaba, Md Ali, et al.. (2024). Formulation Development and Characterization of Lovastatin Nanogel for the Treatment of Hyperlipidemia. Oriental Journal Of Chemistry. 40(4). 945–951. 1 indexed citations
14.
Alam, Md Tauquir, Md Ali Mujtaba, Afzal Hussain, et al.. (2022). Solid-Phase Extraction (SPE) Technique to Quantify Cefdinir in Human Plasma Using Liquid Chromatography–Tandem Mass Spectrometry (LC–MS/MS). Journal of Chromatographic Science. 61(4). 366–374. 3 indexed citations
15.
Mujtaba, Md Ali. (2021). Development of Apigenin-Loaded Niosomes Using Ecological Probe Sonication Technique for Enhanced Oral Delivery: Application of Box- Behnken Design. Current Pharmaceutical Biotechnology. 23(6). 882–893. 5 indexed citations
16.
Mujtaba, Md Ali, et al.. (2021). An Updated Review on Therapeutic Potential and Recent Advances in Drug Delivery of Berberine: Current Status and Future Prospect. Current Pharmaceutical Biotechnology. 23(1). 60–71. 34 indexed citations
17.
Md, Shadab, Nabil A. Alhakamy, Thikryat Neamatallah, et al.. (2021). Development, Characterization, and Evaluation of α-Mangostin-Loaded Polymeric Nanoparticle Gel for Topical Therapy in Skin Cancer. Gels. 7(4). 230–230. 28 indexed citations
18.
Akhter, Md Habban, Md. Rizwanullah, Javed Ahmad, et al.. (2020). Molecular Targets and Nanoparticulate Systems Designed for the Improved Therapeutic Intervention in Glioblastoma Multiforme. Drug Research. 71(3). 122–137. 25 indexed citations
19.
Mujtaba, Md Ali, et al.. (2019). EVALUATION OF COMMUNITY PHARMACIST DISPENSING AND COUNSELLING PRACTICE. International Journal of Biology Pharmacy and Allied Sciences. 8(6). 1 indexed citations
20.
Mujtaba, Md Ali & Kanchan Kohli. (2016). In vitro/in vivo evaluation of HPMC/alginate based extended-release matrix tablets of cefpodoxime proxetil. International Journal of Biological Macromolecules. 89. 434–441. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026